Risk stratification in IgAN
May 2023
A study demonstrating the value of IgAN237, a peptide based classifier that guides intervention in IgA nephropathy has been accepted for publication in the leading journal Nephrology, Dialysis and Transplantation. The study showed that the urinary IgAN237 classifier represents a risk stratification tool in IgAN not only at the time of biopsy but also later in the course of the disease. IgAN237 may guide physicians in management and follow-up strategies in an individualized manner.
